Evidence map›Paper›PMID 41737512›Full record

ArticleJournal of contemporary brachytherapy2025

Dosimetric comparison between manual and inverse optimization methods in high-dose-rate intracavitary/ interstitial cervical cancer brachytherapy for two treatment planning systems.

Lisa Mahe, Leonel Varela Cagetti, Juliette Myxa, Laurence Gonzague-Casabianca, Pierre Fau, Hugues Mailleux, Agnès Tallet, Marjorie Ferre

Abstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa MaheDepartment of Medical Physics, Institut Paoli-Calmettes, Marseille, France.
Leonel Varela CagettiDepartment of Radiation Oncology, Institut Paoli-Calmettes, Marseille, France.
Juliette MyxaDepartment of Medical Physics, Institut Paoli-Calmettes, Marseille, France.
Laurence Gonzague-CasabiancaDepartment of Radiation Oncology, Institut Paoli-Calmettes, Marseille, France.
Pierre FauDepartment of Medical Physics, Institut Paoli-Calmettes, Marseille, France.
Hugues MailleuxDepartment of Medical Physics, Institut Paoli-Calmettes, Marseille, France.
Agnès TalletDepartment of Radiation Oncology, Institut Paoli-Calmettes, Marseille, France.
Marjorie FerreDepartment of Medical Physics, Institut Paoli-Calmettes, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To compare manual treatment planning with two inverse planning methods from two different treatment planning systems for high-dose-rate cervical cancer brachytherapy. Material and methods: Thirty-one consecutive patients were included. Three treatment plans were created: manual, hybrid inverse treatment planning (HIPO), and RayStation Brachy (RSB), using Oncentra TPS for manual and HIPO, and RayStation TPS for RSB. Dose volume parameters, dwell time in intrauterine tandem, ovoids, and interstitial needles as well as Paddick, COIN, and dwell time inhomogeneity index, were evaluated. Results: Compared with manual planning, HIPO plans resulted in a higher dose to targets while reducing the dose to organs at risk. It reduced the total treatment time and increased the loading in interstitial needles. RSB plans resulted in a similar dose to targets and organs at risk and a similar total treatment time, but a better homogeneity of dose distribution. All dosimetric indices were increased with inverse optimization. Conclusions: Both inverse planning methods are able to produce dosimetrically acceptable plans, with an increase of target coverage and better homogeneity. RSB provides higher doses and better homogeneity than HIPO.

Indexed as

brachytherapyhigh-dose-rateHIPOinverse optimizationlocally advanced cervical cancerRayStation Brachy

Identifiers

PMID41737512
PMCPMC12928142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.